| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +6.25M | 99.9% | $2.40 | +$15M |
| Sells | 1 | -5.9K | 0.1% | $1.43 | -$8.44K |
| Net | +1 | +6.24M | 99.8% | +$15M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Orbimed Advisors Llc | Director, 10%+ Owner | $3.01M | +$7.5M | Jan 25, 2024 | |
| Carl L. Gordon | Director, 10%+ Owner | $942K | +$7.5M | Aug 21, 2024 | |
| Chen Schor | President & CEO, Director | $629K | Jun 5, 2024 | ||
| Francesco Galimi | SVP & Chief Medical Officer | $244K | Jun 5, 2024 | ||
| Brian Nicholas Harvey | Chief Financial Officer | $240K | Jun 5, 2024 | ||
| Aya Jakobovits | Director | $214K | Aug 21, 2024 | ||
| Don Healey | Chief Technology Officer | $174K | Jun 5, 2024 | ||
| Blake Aftab | Chief Scientific Officer | $150K | Jun 5, 2024 | ||
| Lloyd Klickstein | Director | $147K | Aug 19, 2024 | ||
| Andrew Sinclair | Director | $28.3K | Aug 21, 2024 | ||
| Steve Dubin | Director | $24K | Aug 21, 2024 | ||
| Jeffrey Chodakewitz | Director | $16.9K | Aug 21, 2024 | ||
| Katie Peng | Director | $14.2K | Aug 21, 2024 | ||
| Michael Kauffman | Director | $8.44K | -$8.44K | -50% | Aug 21, 2024 |
| Stewart Abbot | Former Chief Scientific and Operating Officer | Jun 11, 2021 | |||
| Bastiano Sanna | Director | Aug 14, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|